Vimarsana
Biggest News Aggregation in the World

Page 2 - Trait Factory News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Trait Factory. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Trait Factory Today - Breaking & Trending Today

Yield10 Bioscience (NASDAQ:YTEN) Stock Price Crosses Above 200 Day Moving Average of $2.61 - Vimarsana News

Yield10 Bioscience (NASDAQ:YTEN) Stock Price Crosses Above 200 Day Moving Average of $2.61

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

Yield10 Bioscience, Inc. (YTEN) Q3 2022 Earnings Call Transcript - Vimarsana News

Yield10 Bioscience, Inc. (YTEN) Q3 2022 Earnings Call Transcript

Yield10 Bioscience, Inc. (NASDAQ:NASDAQ:YTEN) Q3 2022 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Lynne Brum – Vice President of Planning and Corporate...

Yield10 Bioscience, Inc. (YTEN) CEO Oliver Peoples on Q2 2022 Results - Earnings Call Transcript - Vimarsana News

Yield10 Bioscience, Inc. (YTEN) CEO Oliver Peoples on Q2 2022 Results - Earnings Call Transcript

Yield10 Bioscience, Inc. (NASDAQ:NASDAQ:YTEN) Q2 2022 Earnings Conference Call August 10, 2022, 16:30 ET Company Participants Lynne Brum - VP, Planning & Corporate Communications &...

Yield10 Bioscience (NASDAQ:YTEN) Lifted to Buy at Zacks Investment Research - Vimarsana News

Yield10 Bioscience (NASDAQ:YTEN) Lifted to Buy at Zacks Investment Research

Yield10 Bioscience (NASDAQ:YTEN – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Thursday, Zacks.com reports. The brokerage presently has a $2.75 price target on the specialty chemicals company’s stock. Zacks Investment Research‘s price objective would indicate a potential upside of 9.13% from […]

Yield10 Bioscience (NASDAQ:YTEN) Cut to Hold at Zacks Investment Research - Vimarsana News

Yield10 Bioscience (NASDAQ:YTEN) Cut to Hold at Zacks Investment Research

Yield10 Bioscience (NASDAQ:YTEN – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research report issued on Wednesday, Zacks.com reports. According to Zacks, “Yield10 Bioscience, Inc. is an agricultural bioscience company. It focuses on the development of disruptive technologies for improvement in crop yield to enhance […]